1iy7: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
Line 1: Line 1:
[[Image:1iy7.gif|left|200px]]
{{Seed}}
[[Image:1iy7.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1iy7|  PDB=1iy7  |  SCENE=  }}  
{{STRUCTURE_1iy7|  PDB=1iy7  |  SCENE=  }}  


'''Crystal Structure of CPA and sulfamide-based inhibitor complex'''
===Crystal Structure of CPA and sulfamide-based inhibitor complex===




==Overview==
<!--  
N-Sulfamoylphenylalanine and its derivatives having varied alkyl groups on the terminal amino group were designed rationally as transition state analogue inhibitors for carboxypeptidase A (CPA) and synthesized. In CPA inhibitory assays the parent compound having the (S)-configuration, i.e., (S)-1a, showed potent inhibitory activity with the K(i) value of 0.64 microM. Its enantiomer was shown to be much less potent (K(i) = 470 microM). Introduction of an alkyl group such as methyl or isopropyl group on the terminal amino group of (S)-1a lowered the inhibitory potency drastically. Introduction of a methyl group on the internal amino group of (S)-1a also caused a drastic reduction of the inhibitory activity. The structure of the CPA x(S)-1a complex determined by single-crystal X-ray diffraction reveals that the sulfamoyl moiety interacts with the zinc ion and functional groups at the active site of CPA, which is reminiscent of the postulated stabilization mode of a tetrahedral transition state in the CPA-catalyzed hydrolysis of a peptide substrate. On the basis of the design rationale and the binding mode of (S)-1a to CPA shown by X-ray crystallographic analysis, the present inhibitors are inferred to be a novel type of transition state analogue inhibitor for CPA.
The line below this paragraph, {{ABSTRACT_PUBMED_12431056}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 12431056 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_12431056}}


==About this Structure==
==About this Structure==
Line 29: Line 33:
[[Category: Woo, J R.]]
[[Category: Woo, J R.]]
[[Category: Protein-inhibitor complex]]
[[Category: Protein-inhibitor complex]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 20:34:18 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 14:12:31 2008''

Revision as of 11:12, 1 July 2008

File:1iy7.png

Template:STRUCTURE 1iy7

Crystal Structure of CPA and sulfamide-based inhibitor complex

Template:ABSTRACT PUBMED 12431056

About this Structure

1IY7 is a Single protein structure of sequence from Bos taurus. Full crystallographic information is available from OCA.

Reference

Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases., Park JD, Kim DH, Kim SJ, Woo JR, Ryu SE, J Med Chem. 2002 Nov 21;45(24):5295-302. PMID:12431056

Page seeded by OCA on Tue Jul 1 14:12:31 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1iy7&oldid=614105"